Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection

BACKGROUND: Interest in phage therapy has grown over the past decade due to the rapid emergence of antibiotic resistance in bacterial pathogens. However, the use of bacteriophages for therapeutic purposes has raised concerns over the potential for immune response, rapid toxin release by the lytic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Vivek Daniel, Sundarrajan, Sudarson, Rajagopalan, Sanjeev Saravanan, Hariharan, Sukumar, Kempashanaiah, Nanjundappa, Padmanabhan, Sriram, Sriram, Bharathi, Ramachandran, Janakiraman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224134/
https://www.ncbi.nlm.nih.gov/pubmed/21880144
http://dx.doi.org/10.1186/1471-2180-11-195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224134/
https://www.ncbi.nlm.nih.gov/pubmed/21880144
http://dx.doi.org/10.1186/1471-2180-11-195

Ejemplares similares